Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion

Experimental Physiology

Volumn 94, Issue 8, 2009, Pages 937-946

  Mecca, Adam P ^a   O'Connor, Timothy E ^a   Katovich, Michael J ^a   Sumners, Colin ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GRAY MATTER; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

EID: 67749089564     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.047936     Document Type: Article

References (39)

1. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL & Bartkowski H (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472 476.
2. Biernaskie J, Corbett D, Peeling J, Wells J & Lei H (2001). A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn Reson Med 46, 827 830.
3. 2 receptor comes of age. Hypertension 45, 840 844.
4. 2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 274, 31686 31692.
5. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S & Wedel H (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995 1003. (Pubitemid 34286536)
6. 1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30, 2391 2398 discussion 2398-2399.
7. Faure S, Bureau A, Oudart N, Javellaud J, Fournier A & Achard JM (2008). Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J Hypertens 26, 2008 2015.
8. Garcia JH, Wagner S, Liu KF & Hu XJ (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627 634 discussion 635.
9. Glendenning ML, Lovekamp-Swan T & Schreihofer DA (2008). Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats. Neurosci Lett 445, 188 192.
10. Gonzalez CL & Kolb B (2003). A comparison of different models of stroke on behaviour and brain morphology. Eur J Neurosci 18, 1950 1962.
11. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK & Katovich MJ (2007). Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292, H736 H742.
12. Groth W, Blume A, Gohlke P, Unger T & Culman J (2003). Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21, 2175 2182. (Pubitemid 38296880)
13. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO & Björck JE (1999). Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611 616. (Pubitemid 29087980)
14. Horiuchi M, Akishita M & Dzau VJ (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613 621. (Pubitemid 29091636)
15. Inada Y, Wada T, Ojima M, Sanada T, Shibouta Y, Kanagawa R, Ishimura Y, Fujisawa Y & Nishikawa K (1997). Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 19, 1079 1099.
16. 1 antagonist. Stroke 33, 2297 2303.
17. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T & Horiuchi M (2004). Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843 848.
18. Kagiyama T, Glushakov AV, Sumners C, Roose B, Dennis DM, Phillips MI, Ozcan MS, Seubert CN & Martynyuk AE (2004). Neuroprotective action of halogenated derivatives of l-phenylalanine. Stroke 35, 1192 1196.
19. Kagiyama T, Kagiyama S & Phillips MI (2003). Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul Pept 110, 241 247. (Pubitemid 36165062)
20. Krikov M, Thone-Reineke C, Muller S, Villringer A & Unger T (2008). Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J Hypertens 26, 544 552.
21. Li H, Gao Y, Freire CD, Raizada MK, Toney GM & Sumners C (2006). Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II. FASEB J 20, 1748 1750.
22. Li J, Culman J, Hörtnagl H, Zhao Y, Gerova N, Timm M, Blume A, Zimmermann M, Seidel K, Dirnagl U & Unger T (2005). Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19, 617 619.
23. Li JM, Mogi M, Iwanami J, Min LJ, Tsukuda K, Sakata A, Fujita T, Iwai M & Horiuchi M (2008). Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density. Stroke 39, 2029 2036.
24. Liu H, Kitazato KT, Uno M, Yagi K, Kanematsu Y, Tamura T, Tada Y, Kinouchi T & Nagahiro S (2008). Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies. J Hypertens 26, 1435 1445.
25. Lu Q, Zhu YZ & Wong PT (2005). Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats. Neuroreport 16, 1963 1967. (Pubitemid 41653523)
26. 2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 188, 661 670.
27. 2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 44, 1482 1489.
28. Makino I, Shibata K, Ohgami Y, Fujiwara M & Furukawa T (1996). Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain. Neuropeptides 30, 596 601.
29. 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31, 2478 2486.
30. Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P & Zanchetti A (2004). Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 44, 1175 1180.
31. 2 receptor and the transcription factor NF-κB. FASEB J 17, 2094 2096.
32. Sharkey J & Butcher SP (1995). Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods 60, 125 131.
33. 1 receptor-mediated contraction in rats. Stroke 35, 970 974.
34. Stier CT Jr., Adler LA, Levine S & Chander PN (1993). Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl 11, S37 S42.
35. Takada J, Ibayashi S, Ooboshi H, Ago T, Ishikawa E, Kamouchi M, Kitazono T & Iida M (2006). Valsartan improves the lower limit of cerebral autoregulation in rats. Hypertens Res 29, 621 626.
36. 2 receptors in the rat skin during experimental wound healing. Peptides 13, 783 786.
37. Walther T, Olah L, Harms C, Maul B, Bader M, Hörtnagl H, Schultheiss HP & Mies G (2002). Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16, 169 176. (Pubitemid 34113010)
38. Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J & Corbett D (2006). An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201, 324 334.
39. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H & Kim-Mitsuyama S (2008). Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39, 3049 3056.